PBMC from patients with chronic granulomatous disease exhibited a lower IL-17A production upon stimulation with Aspergillus and Candida compared to healthy donors, and this might contribute to ineffective fungal clearance in these patients [63]. This evidence concerns the gene IL17A and chronic granulomatous disease.